Results 171 to 180 of about 14,551 (210)
Some of the next articles are maybe not open access.
Chronic inflammatory demyelinating polyneuropathy
Current Opinion in Neurology, 2007Purpose of review As a syndrome with typical and atypical cases, chronic inflammatory demyelinating polyneuropathy (CIDP) has been a difficult disorder to diagnose and treat. The pathophysiologic basis for CIDP has not been established, contributing to the challenges in dealing with these patients.
openaire +3 more sources
Chronic inflammatory demyelinating polyneuropathy
Neuromuscular Disorders, 2006Chronic inflammatory demyelinative polyneuropathy (CIDP) is an acquired neuropathy, presumably of immunological origin. Its clinical presentation and course are extremely variable. CIDP is one of the few peripheral neuropathies amenable to treatment. Typical cases associate progressive or relapsing-remitting motor and sensory deficit with increased CSF
openaire +3 more sources
Atypical chronic inflammatory demyelinating polyneuropathies
Journal of Neurology, Neurosurgery & Psychiatry, 2018Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy progressive for more than 2 months, including several clinical subtypes.1 2 In 1975, Dyck et al 3 described the classical prototype of CIDP, and emphasised that a prominent clinical feature is weakness of the proximal and distal muscles about equally which is very
Satoshi Kuwabara +2 more
openaire +2 more sources
Chronic inflammatory demyelinating polyneuropathy (CIDP)
Acta Neurologica Scandinavica, 2012Chronic immune-mediated demyelinating polyneuropathies can often lead to severe neurologic disability.Literature review and personal experience with these types of neuropathies.It is important to recognize these immune-mediated neuropathies as they respond to treatment.
C A, Vedeler, E, Farbu, S I, Mellgren
openaire +2 more sources
Chronic inflammatory demyelinating polyneuropathy
Current Treatment Options in Neurology, 1999Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) requires long-term immunomodulatory therapy, which has potential side effects. Before such therapy is instituted, a firm diagnosis of CIDP must be established. Prednisone, plasma exchange (PE), and intravenous immunoglobulin (IVIG) are all proven first-line therapies for CIDP that ...
, Gorson, , Chaudhry
openaire +2 more sources
Childhood chronic inflammatory demyelinating polyneuropathy
European Journal of Paediatric Neurology, 1998Chronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic disorder of the peripheral nervous system with sensory and motor involvement, and insidious onset over a period of months. In children and adults, both proximal and distal muscles are affected. Muscle stretch reflexes are absent or depressed.
openaire +2 more sources
Chronic inflammatory demyelinating polyneuropathy.
International journal of tissue reactions, 1985In 12 cases of CIDP under surveillance for 14 years, the main nerve biopsy findings were endoneural oedema and demyelination of nerve fibres. IgM deposition was found in 1 patient and IgG deposits in another. Electron microscopy revealed proliferation of the Schwann cells and mononuclear cell infiltration.
RIZZUTO, Nicolo', SIMONATI, Alessandro
openaire +2 more sources
Chronic inflammatory demyelinating polyneuropathy
Neuromuscular Disorders, 1996BRIANI, CHIARA +3 more
openaire +3 more sources
"Minimal" chronic inflammatory demyelinating polyneuropathy
1997-
DI MUZIO, ANTONIO +4 more
openaire +2 more sources
Chronic Inflammatory Demyelinating Polyneuropathy
Seminars in Neurology, 1993G A, Small, R E, Lovelace
openaire +3 more sources